🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People

RecruitingNAAges 75 Years - anyAllUmeå University
NCT03671629 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients \>75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Living at home * Acutely admitted * Registered at one of ten pre-specified primary care health centers Exclusion Criteria: * Patients unable to communicate or who do not speak Swedish * Patients scheduled for palliative care * Patients admitted due to intoxication by alcohol or drug (non prescription)
💊

What it tests

  • Enhanced clinical pharmacist service
📍

Where

1 site
Medical Centre, University Hospital of Umeå
Umeå, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy